Neuromuscular Disorders

Papers
(The H4-Index of Neuromuscular Disorders is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
WMS General Information69
ENMC Themed Workshop announcement41
WMS General Information37
Editorial Board36
ENMC Mid-Career Mentoring Programme35
366P Social Vulnerability in Duchenne Muscular Dystrophy: The Impact on Boys and Carrier Mothers33
156P Phosphorylated neurofilament heavy chain in cerebrospinal fluid and plasma in clinically silent and childhood-onset SMA individuals from Serbia31
355P A comprehensive education and training programme for healthcare professionals in care and research for Duchenne muscular dystrophy developed from DMD Care UK and the DMD Hub28
624P A new double-trouble phenotype: fascioscapulohumeral muscular dystrophy and familial amyotrophic lateral sclerosis.27
326P Acute adverse events after Zoledronic acid infusion are uncommon in patients with Duchenne muscular dystrophy previously treated with oral bisphosphonates25
81P Minimal clinically important differences in dysferlinopathy from the 10-year, multicenter Jain Clinical Outcome Study25
95P Development of a myotropic gene therapy towards a first treatment for LGMDR723
279P Exploring myogenic tremor in an animal model of MYBPC1-associated myopathy: a comprehensive study23
365P Duchenne video assessment 2.0 scorecard performance: evaluation of inter-item and inter-scorecard relationships22
WMS 2024 Full Programme22
46P Congenital myopathies and muscular dystrophies in the UK: a comprehensive next generation sequencing analysis of frequencies over an 8-year period (2016-2023)21
389P Natural history of bone health in Duchenne muscular dystrophy: A systematic review and implications for the design of a clinical trial21
17O Schwann cell transduction and PMP22 target engagement in non-human primates supports translation of RNAi-based gene therapy for CMT1A21
10O The neonatal screening of SMA in Ukraine: the 18 months of experience20
203P Towards a better analysis of SMN2 structures and variants by complete sequencing of the SMN locus in an international cohort of 564 SMA patients20
0.15272498130798